Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2022-12-31$1.89/sh−3$6→ 14,428 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.